This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2000 Aug 12;356(9229):597.

doi: 10.1016/s0140-6736(05)73980-5.

Neuroprotection disappointment yet aGAIN

J M Wardlaw, C P Warlow, P A Sandercock, M S Dennis, R I Lindley

PMID: 10950263
DOI: 10.1016/s0140-6736(05)73980-5

Comment

Neuroprotection disappointment yet aGAIN

J M Wardlaw et al. Lancet. 2000.

. 2000 Aug 12;356(9229):597.

doi: 10.1016/s0140-6736(05)73980-5.

Authors

J M Wardlaw, C P Warlow, P A Sandercock, M S Dennis, R I Lindley

PMID: 10950263
DOI: 10.1016/s0140-6736(05)73980-5

No abstract available

PubMed Disclaimer

Comment on

Glycine antagonist (gavestinel) in neuroprotection (GAIN International) in patients with acute stroke: a randomised controlled trial. GAIN International Investigators.
Lees KR, Asplund K, Carolei A, Davis SM, Diener HC, Kaste M, Orgogozo JM, Whitehead J. Lees KR, et al. Lancet. 2000 Jun 3;355(9219):1949-54. doi: 10.1016/s0140-6736(00)02326-6. Lancet. 2000. PMID: 10859040 Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information